SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
115.274 1.52 (1.34%)

NAV as on 18 Dec, 2014

CRISIL MF RANK

Not Ranked

Scheme Risk Grade

  HIGH RISK

HIGH RISK

  • For investors looking at long term capital growth investments.
  • Ideal for people who wish to benefit from potentially higher returns and have the risk appetite for the same.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL (for quarter ended Mar 2014) since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on 18 Dec, 2014)

Period Returns (%) Rank #
1 mth -1.5 2
3 mth 5.9 2
6 mth 34.8 2
1 year 53.2 2
2 year 38.2 2
3 year 38.6 1
5 year 26.7 1

# Moneycontrol Rank within 6 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2014 4.2 14.8 23.7 - -
2013 -3.0 9.0 6.4 8.4 25.7
2012 9.4 5.5 12.4 6.3 37.3
2011 -6.1 6.8 -8.3 2.9 -5.6
2010 4.6 9.8 -0.3 9.5 29.6
2009 -11.3 43.8 26.2 -0.2 81.2

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns -1.5 5.9 34.8 53.2 38.2 38.6 26.7
Category avg -1.7 3.2 32.3 48.1 34.2 17.0 11.9
Difference of Fund returns and Category returns 0.2 2.7 2.5 5.1 4.0 21.6 14.8
Best of category -1.5 6.2 35.5 54.6 38.6 38.6 26.7
Worst of category -1.9 1.4 29.2 41.3 31.1 29.3 21.8
Benchmark returns # -2.7 2.9 31.9 46.2 32.5 35.2 23.2
Difference of Fund returns and Benchmark returns 1.2 3.0 2.9 7.0 5.7 3.4 3.5
# Benchmark Index: S&P BSE HEALTHCARE

Investment Info

Investment Objective

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes viz.Information Technology, Pharmaceuticals,FMCG, Contrarian (investment in stocks currently out of favour) and Emerging Businesses.

Scheme details

Fund Type Open-Ended
Investment Plan Growth
Launch date Jul 31, 1999
Benchmark S&P BSE HEALTHCARE
Asset Size (Rs cr) 233.71 (Sep-30-2014)
Minimum Investment Rs.50000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Tanmaya Desai
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 0.00%
Load Comments Exit load charge will be nil w.e.f. Oct 10, 2013.

Contact Details

Regd. Office 191 Maker Towers E, Cuffe Parade, Mumbai, 400005
Tel. No. 91 22 22180221/ 27
Fax No. 91 22 22189663
Email partnerforlife@sbimf.com
Website http://www.sbimf.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
899.58 1.9 32.0 47.9 33.9 23.1
Reliance Pharma Fund - Direct (G) Not Ranked
44.84 2.1 32.5 49.0 -- --
UTI Pharma & Health (G) Not Ranked
178.88 1.4 29.2 41.3 29.3 21.8
UTI Pharma & Health - Direct (G) Not Ranked
5.95 1.7 29.8 42.5 -- --
SBI Pharma Fund (G) Not Ranked
233.71 5.9 34.8 53.2 38.6 26.7
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Nov 28, 14)

Equity Sector Value
(Rs cr)
Asset %
No Holdings Data Available

Full Portfolio

Sector Allocation (Nov 28, 14)

Sector %

1-Year

HighLow

No Sector Data Available

View All Sectors

Asset Allocation (%)(Nov 28, 14)

Equity 98.16
Others 0.28
Debt 0.00
Mutual Funds N.A
Money Market 1.84
Cash / Call -0.29

View All

Sector (%)
Top 3 N.A.

News & Videos

Messages & Community

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.